• Skip to primary navigation
  • Skip to content
  • Skip to footer

Vytronus

Vytronus

  • Technology
  • Clinical
  • About
  • News
  • Careers
  • Contact

News

July 29, 2016

Vytronus, Inc. Raises $49 Million Series C Financing

Vytronus, Inc. (“Vytronus”), a privately held medical device company developing novel technologies for the treatment of cardiac arrhythmias, announced today that it has secured $49 million in Series C equity financing. The current syndicate of investors enthusiastically supported this financing. Proceeds will be used for technology refinements and clinical trials of VytronUS’s proprietary Low-Intensity Collimated Ultrasound (LICU™) Cardiac Mapping & Ablation System to treat atrial fibrillation and other arrhythmias.

Footer

Vytronus, Inc.
658 North Pastoria Ave.
Sunnyvale, CA 94085

phone: (408) 730-1333
email: moc.s1576186879unort1576186879yv@of1576186879ni1576186879

  • Technology
  • Clinical
  • About
  • News
  • Careers
  • Contact

Investigational Device Only. Not Approved for sale.                                                                          

© 2019 Vytronus, Inc. All Rights Reserved.